Skip to main content
Erschienen in: Urolithiasis 3/2018

30.03.2017 | Original Paper

Supracostal access for miniaturized percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches

Erschienen in: Urolithiasis | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

In this study, we aimed to evaluate the efficiency and safety of supracostal and subcostal approaches during miniaturized percutaneous nephrolithotomy (mPNL). In two tertiary academic centers, we retrospectively analyzed the charts of patients who had undergone mPNL between January 2011 and June 2015 for the treatment of renal stones. Enrolled in the study were 49 patients who had access through the supracostal area (Group 1) and, to serve as controls, 49 patients who were accessed through the subcostal area (Group 2). To avoid potential bias between the groups, the patients were retrospectively matched one-on-one with respect to age, gender, body mass index, ASA score, and size and number of stones. The presence of upper calyx stones and distorted lower calyx anatomy were the most common reasons for performing supracostal access (57.1 and 28.6%, respectively). Access through 11–12 intercostal space was performed in 46 patients (93.9%), and the other three supracostal accesses (6.1%) were performed through the 10–11 intercostal area. The complication rates were 14.3% in Group 1 and 16.3% in Group 2 (p = 0.952). Final stone-free status had increased to 89.8 and 87.8% in Groups 1 and 2, respectively (p = 0.942). Our study demonstrated that mPNL resulted in acceptable stone-free rates whether accessed through either the supracostal or subcostal areas. Moreover, the supracostal approach with mPNL had no negative effect on any intraoperative and postoperative parameters, nor did it increase complication rates.
Literatur
1.
Zurück zum Zitat Mirheydar HS, Palazzi KL, Derweesh IH, et al (2013) Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. Endourol 27:979–983CrossRef Mirheydar HS, Palazzi KL, Derweesh IH, et al (2013) Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. Endourol 27:979–983CrossRef
2.
Zurück zum Zitat Raza A, Moussa S, Smith G et al (2008) Upper pole puncture in percutaneous nephrolithotomy: a retrospective review of treatment, safety and efficacy. BJU Int 101:599–602CrossRefPubMed Raza A, Moussa S, Smith G et al (2008) Upper pole puncture in percutaneous nephrolithotomy: a retrospective review of treatment, safety and efficacy. BJU Int 101:599–602CrossRefPubMed
3.
Zurück zum Zitat Mishra S, Sharma R, Garg C et al (2011) Prospective comparative study of mini perc and standard PNL for treatment of 1 to 2 cm size renal stone. BJU Int 108:896–899PubMed Mishra S, Sharma R, Garg C et al (2011) Prospective comparative study of mini perc and standard PNL for treatment of 1 to 2 cm size renal stone. BJU Int 108:896–899PubMed
4.
Zurück zum Zitat Turna B, Nazli O, Demiryoguran S, Mammadov R, Cal C (2007) Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology 269:603–607CrossRef Turna B, Nazli O, Demiryoguran S, Mammadov R, Cal C (2007) Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology 269:603–607CrossRef
5.
Zurück zum Zitat El-Nahas AR, Shokeir AA, El-Assmy AM et al (2007) Post-percutaneous nephrolithotomy extensive hemorrhage: a study of risk factors. J Urol 177:576–579CrossRefPubMed El-Nahas AR, Shokeir AA, El-Assmy AM et al (2007) Post-percutaneous nephrolithotomy extensive hemorrhage: a study of risk factors. J Urol 177:576–579CrossRefPubMed
6.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Gupta R, Kumar A, Kapoor R et al (2002) Prospective evaluation of safety and efficacy of the supracostal approach for percutaneous nephrolithotomy. BJU Int 90:809–813CrossRefPubMed Gupta R, Kumar A, Kapoor R et al (2002) Prospective evaluation of safety and efficacy of the supracostal approach for percutaneous nephrolithotomy. BJU Int 90:809–813CrossRefPubMed
8.
Zurück zum Zitat Radecka E, Brehmer M, Holmgren K et al (2003) Complications associated with percutaneous nephrolithotripsy: Supra-versus subcostal access. Acta Radiol 44:447–451PubMed Radecka E, Brehmer M, Holmgren K et al (2003) Complications associated with percutaneous nephrolithotripsy: Supra-versus subcostal access. Acta Radiol 44:447–451PubMed
9.
Zurück zum Zitat McAllister M, Lim K, Torrey R et al (2011) Intercostal vessels and nerves are at risk for injury during supracostal percutaneous nephrostolithotomy. J Urol 185:329–334CrossRefPubMed McAllister M, Lim K, Torrey R et al (2011) Intercostal vessels and nerves are at risk for injury during supracostal percutaneous nephrostolithotomy. J Urol 185:329–334CrossRefPubMed
10.
Zurück zum Zitat Munver R, Delvecchio FC, Newman GE et al (2001) Critical analysis of supracostal access for percutaneous renal surgery. J Urol 166:1242–1246CrossRefPubMed Munver R, Delvecchio FC, Newman GE et al (2001) Critical analysis of supracostal access for percutaneous renal surgery. J Urol 166:1242–1246CrossRefPubMed
11.
Zurück zum Zitat Shaban A, Kodera A, El Ghoneimy MN et al (2008) Safety and efficacy of supracostal access in percutaneous renal surgery. J Endourol 22:29–34CrossRefPubMed Shaban A, Kodera A, El Ghoneimy MN et al (2008) Safety and efficacy of supracostal access in percutaneous renal surgery. J Endourol 22:29–34CrossRefPubMed
12.
Zurück zum Zitat Cheng F, Yu W, Zhang X et al (2010) Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol 24:1579–1582CrossRefPubMed Cheng F, Yu W, Zhang X et al (2010) Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol 24:1579–1582CrossRefPubMed
13.
Zurück zum Zitat Lojanapiwat B, Prasopsuk S (2006) Upper pole access for percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches. J Endourol 20:391–395 Lojanapiwat B, Prasopsuk S (2006) Upper pole access for percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches. J Endourol 20:391–395
14.
Zurück zum Zitat Lang E, Thomas R, Davis R et al (2009) Risks, advantages, andcomplications of intercostal vs subcostal approach for percutaneous nephrolithotripsy. Urology 74:751–755CrossRefPubMed Lang E, Thomas R, Davis R et al (2009) Risks, advantages, andcomplications of intercostal vs subcostal approach for percutaneous nephrolithotripsy. Urology 74:751–755CrossRefPubMed
15.
Zurück zum Zitat Bjurlin MA, O’Grady T, Kim R, Jordan MD, Goble SM, Hollowel MP (2012) Is routine postoperative chest radiography needed after percutaneous nephrolithotomy? Urology 79:791–795CrossRefPubMed Bjurlin MA, O’Grady T, Kim R, Jordan MD, Goble SM, Hollowel MP (2012) Is routine postoperative chest radiography needed after percutaneous nephrolithotomy? Urology 79:791–795CrossRefPubMed
16.
Zurück zum Zitat Ogan K, Corwin TS, Smith T et al (2003) Sensitivity of chest fluoroscopy compared with chest CT and chest radiography for diagnosing hydropneumothorax in association with percutaneous nephrostolithotomy. Urology 62:988–992CrossRefPubMed Ogan K, Corwin TS, Smith T et al (2003) Sensitivity of chest fluoroscopy compared with chest CT and chest radiography for diagnosing hydropneumothorax in association with percutaneous nephrostolithotomy. Urology 62:988–992CrossRefPubMed
Metadaten
Titel
Supracostal access for miniaturized percutaneous nephrolithotomy: comparison of supracostal and infracostal approaches
Publikationsdatum
30.03.2017
Erschienen in
Urolithiasis / Ausgabe 3/2018
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-017-0976-z

Weitere Artikel der Ausgabe 3/2018

Urolithiasis 3/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.